Your browser doesn't support javascript.
loading
Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge.
Wolf, Douglas C; Cohen, Samuel M; Boobis, Alan R; Dellarco, Vicki L; Fenner-Crisp, Penelope A; Moretto, Angelo; Pastoor, Timothy P; Schoeny, Rita S; Seed, Jennifer G; Doe, John E.
Afiliação
  • Wolf DC; Syngenta Crop Protection LLC, Greensboro, NC, 27419, USA.
  • Cohen SM; Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE, 68198-3135, USA.
  • Boobis AR; Centre for Pharmacology & Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.
  • Dellarco VL; Independent Consultant, Silver Spring, MD, 20901, USA.
  • Fenner-Crisp PA; Independent Consultant, North Garden, VA, 22959, USA.
  • Moretto A; Dipartimento di Scienze Biochimiche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Milan, Italy.
  • Pastoor TP; Pastoor Science Communication, LLC, Greensboro, NC, 27455, USA.
  • Schoeny RS; Rita Schoeny LLC, Washington DC, 20002, USA.
  • Seed JG; Independent Consultant, Alexandria, VA, 22301, USA.
  • Doe JE; Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire, SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.
Regul Toxicol Pharmacol ; 103: 86-92, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30634023
Developments in the understanding of the etiology of cancer have profound implications for the way the carcinogenicity of chemicals is addressed. This paper proposes a unified theory of carcinogenesis that will illuminate better ways to evaluate and regulate chemicals. In the last four decades, we have come to understand that for a cell and a group of cells to begin the process of unrestrained growth that is defined as cancer, there must be changes in DNA that reprogram the cell from normal to abnormal. Cancer is the consequence of DNA coding errors that arise either directly from mutagenic events or indirectly from cell proliferation especially if sustained. Chemicals that act via direct interaction with DNA can induce cancer because they cause mutations which can be carried forward in dividing cells. Chemicals that act via non-genotoxic mechanisms must be dosed to maintain a proliferative environment so that the steps toward neoplasia have time to occur. Chemicals that induce increased cellular proliferation can be divided into two categories: those which act by a cellular receptor to induce cellular proliferation, and those which act via non-specific mechanisms such as cytotoxicity. This knowledge has implications for testing chemicals for carcinogenic potential and risk management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinógenos / Testes de Carcinogenicidade / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinógenos / Testes de Carcinogenicidade / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos